The Prognostic Implications of Circulating Tumor Cells in Patients with Breast Cancer

REFERENCES

• Ashworth T. R. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust. Med. J. 1869; 14: 146–149
   Google Scholar
• Allard W. J., Matera J, Miller M C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer. Res. 2004; 10(20)6897–6904
   PubMed Web of Science ®Google Scholar
• Ross A. A., Cooper B. W., Lazarus H. M., et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocyto-chemical and clonogenic assay techniques. Blood 1993; 82(9)2605–2610
   PubMed Web of Science ®Google Scholar
• Engell H. C. Cancer cells in the blood; a five to nine year follow up study. Ann. Surg. 1959; 149(4)457–461
   PubMed Web of Science ®Google Scholar
• Christopherson W. M. Cancer cells in the peripheral blood: a second look. Acta. Cytol. 1965; 9(2)169–174
   PubMed Web of Science ®Google Scholar
• Choesmel V., Pierga J. Y., Nos C., et al. Enrichment methods to detect bone marrow micro-metastases in breast carcinoma patients: clinical relevance. Breast. Cancer. Res. 2004; 6(5)R556–R570.
   PubMed Web of Science ®Google Scholar
• Rolle A., Gunzel R., Pachmann U., et al. Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J. Surg. Oncol. 2005; 3(1)18
   PubMedGoogle Scholar
• Witzig T. E., Bossy B., Kimlinger T., et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin. Cancer Res. 2002; 8(5)1085–1091
   PubMed Web of Science ®Google Scholar
• Racila E., Euhus D., Weiss A. J., et al. Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. USA 1998; 95(8)4589–4594
   PubMed Web of Science ®Google Scholar
• Brugger W., Buhring H. J., Grunebach F., et al. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J. Clin. Oncol. 1999; 17(5)1535–1544
   PubMed Web of Science ®Google Scholar
• Ahr A., Scharl A., Muller M., et al. Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11. Int. J. Cancer 1999; 84(5)502–505
   PubMed Web of Science ®Google Scholar
• Borgen E., Beiske K., Trachsel S., et al. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J. Pathol. 1998; 185(4)427–434
   PubMed Web of Science ®Google Scholar
• Ring A., Smith I E., Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol. 2004; 5(2)79–88
   PubMed Web of Science ®Google Scholar
• Jung R., Kruger W., Hosch S., et al. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br. J. Cancer 1998; 78(9)1194–1198
   PubMed Web of Science ®Google Scholar
• Goeminne J. C., Guillaume T., Salmon M., et al. Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contami nating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors. Bone Marrow Transplant 1999; 24(7)769–775
   PubMed Web of Science ®Google Scholar
• Fiegl H., Millinger S., Mueller-Holzner E., et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. Cancer Res. 2005; 65(4)1141–1145
   PubMed Web of Science ®Google Scholar
• Brandt B., Roetger A., Heidi S., et al. Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. Int. J. Cancer 1998; 76(6)824–828
   PubMed Web of Science ®Google Scholar
• Martin V. M., Siewert C., Scharl A., et al. Immunomagnetic enrichment of disseminated epi thelial tumor cells from peripheral blood by MACS. Exp. Hematol 1998; 26(3)252–264
   PubMed Web of Science ®Google Scholar
• de Cremoux P, Extra J M., Denis M G., et al. Detection of MUCl-expressing mammary car cinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction. Clin. Cancer Res. 2000; 6(8)3117–3122
   PubMed Web of Science ®Google Scholar
• Kruger W., Datta C., Badbaran A., et al. Immunomagnetic tumor cell selection—impli cations for the detection of disseminated cancer cells. Transfusion 2000; 40(12)1489–1493
   PubMed Web of Science ®Google Scholar
• Beitsch P. D., Clifford E. Detection of carcinoma cells in the blood of breast cancer patients. Am. J. Surg. 2000; 180(6)446–448, discussion 448–449
   PubMed Web of Science ®Google Scholar
• Hu X. C., Wang Y., Shi D. R., et al. Immunomagnetic tumor cell enrichment is promising in detecting circulating breast cancer cells. Oncology 2003; 64(2)160–165
   PubMed Web of Science ®Google Scholar
• Taubert H., Blumke K., Bilkenroth U., et al. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases. Gynecol. Oncol. 2004; 92(1)256–261
   PubMed Web of Science ®Google Scholar
• Kahn H. J., Presta A., Yang L. Y., et al. Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage. Breast Cancer Res. Treat. 2004; 86(3)237–247
   PubMed Web of Science ®Google Scholar
• Cristofanilli M., Budd G. T., Ellis M J, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004; 351(8)781–791
   PubMed Web of Science ®Google Scholar
• Ring A E, Zabaglo L., Ormerod M. G., et al. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br. J. Cancer 2005; 92(5)906–912
   PubMed Web of Science ®Google Scholar
• Bauernhofer T., Zenahlik S., Hofmann G., et al. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer. Oncol. Rep. 2005; 13(2)179–184
   PubMed Web of Science ®Google Scholar
• Pachmann K., Clement J. H., Schneider C. P., et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin. Chem. Lab. Med. 2005; 43(6)617–627
   PubMed Web of Science ®Google Scholar
• Almokadem S., Leitzel K., Harvey H. A., et al. Circulating tumor cells in adjuvant breast cancer patients. J. Clin. Oncol. 2005; 23: 667, (suppl 16)
   PubMedGoogle Scholar
• Gaforio J. J., Serrano M. J., Sanchez-Rovira P., et al. Detection of breast cancer cells in the per ipheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis. Int. J. Cancer 2003; 107(6)984–990
   PubMed Web of Science ®Google Scholar
• Cristofanilli M., Budd G. T., Ellis M. J., et al. Presence of circulating tumor cells (CTC) in metastatic breast cancer (MBC) predicts rapid progression and poor prognosis. J. Clin. Oncol. 2005; 23: 524, (suppl 16)
   Google Scholar
• Cristofanilli M., Hayes D. P., Budd G. T., et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 2005; 23(7)1420–1430
   PubMed Web of Science ®Google Scholar
• Budd G. T., Cristofanilli M., Pllis M., et al. Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC). J Clin Oncol 2005; 23: 503, (suppl 16)
   Google Scholar
• Soria J. C., Gauthier L. R., Raymond P., et al. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin. Cancer. Res. 1999; 5(5)971–975
   PubMed Web of Science ®Google Scholar
• Austrup F., Uciechowski P., Pder C., et al. Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients. Br. J. Cancer 2000; 83(12)1664–1673
   PubMed Web of Science ®Google Scholar
• Fehm T., Sagalowsky A., Clifford P., et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res. 2002; 8(7)2073–2084
   PubMed Web of Science ®Google Scholar
• Hayes D. P., Walker T. M., Singh B., et al. Monitoring expression of HPR-2 on circulating epi thelial cells in patients with advanced breast cancer. Int. J. Oncol. 2002; 21(5)1111–1117
   PubMed Web of Science ®Google Scholar
• Smerage J. B., Doyle G. V., Budd G. T., et al. The detection of apoptosis and Bcl-2 expression in circulating tumor cells (CTCs) from women being treated for metastatic breast cancer. Proc. Am. Assoc. Cancer Res. 2006; 47: 187a
   Google Scholar
• Smirnov D. A., Zweitzig D. R., Foulk B. W., et al. Global gene expression profiling of circulat ing tumor cells. Cancer Res. 2005; 65(12)4993–4997
   PubMed Web of Science ®Google Scholar
• O'Hara S. M., Moreno J. G., Zweitzig D. R., et al. Multigene reverse transcription-PCR profil ing of circulating tumor cells in hormone-refractory prostate cancer. Clin. Chem. 2004; 50(5)826–835
   PubMed Web of Science ®Google Scholar